Nothing Special   »   [go: up one dir, main page]

AU4047497A - Improved detection and therapy of lesions with biotin-chelate conjugates - Google Patents

Improved detection and therapy of lesions with biotin-chelate conjugates

Info

Publication number
AU4047497A
AU4047497A AU40474/97A AU4047497A AU4047497A AU 4047497 A AU4047497 A AU 4047497A AU 40474/97 A AU40474/97 A AU 40474/97A AU 4047497 A AU4047497 A AU 4047497A AU 4047497 A AU4047497 A AU 4047497A
Authority
AU
Australia
Prior art keywords
lesions
biotin
therapy
improved detection
chelate conjugates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU40474/97A
Inventor
Gary L. Griffiths
Hans J. Hansen
Habibe Karacay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunomedics Inc
Original Assignee
Immunomedics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunomedics Inc filed Critical Immunomedics Inc
Publication of AU4047497A publication Critical patent/AU4047497A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU40474/97A 1996-07-31 1997-07-31 Improved detection and therapy of lesions with biotin-chelate conjugates Abandoned AU4047497A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68878196A 1996-07-31 1996-07-31
US08688781 1996-07-31
PCT/US1997/013285 WO1998004293A1 (en) 1996-07-31 1997-07-31 Improved detection and therapy of lesions with biotin-chelate conjugates

Publications (1)

Publication Number Publication Date
AU4047497A true AU4047497A (en) 1998-02-20

Family

ID=24765740

Family Applications (1)

Application Number Title Priority Date Filing Date
AU40474/97A Abandoned AU4047497A (en) 1996-07-31 1997-07-31 Improved detection and therapy of lesions with biotin-chelate conjugates

Country Status (2)

Country Link
AU (1) AU4047497A (en)
WO (1) WO1998004293A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6120768A (en) * 1993-05-17 2000-09-19 Immunomedics, Inc. Dota-biotin derivatives
KR20000052829A (en) 1996-10-28 2000-08-25 조오지 디빈센조, 토브 아스 헬지, 에바 요한손 Improvements in or relating to diagnostic/therapeutic agents
US6261537B1 (en) 1996-10-28 2001-07-17 Nycomed Imaging As Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors
US6331289B1 (en) 1996-10-28 2001-12-18 Nycomed Imaging As Targeted diagnostic/therapeutic agents having more than one different vectors
US7011816B2 (en) * 2001-12-26 2006-03-14 Immunomedics, Inc. Labeling targeting agents with gallium-68 and gallium-67

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5283342A (en) * 1992-06-09 1994-02-01 Neorx Corporation Biotinylated small molecules
US5202451A (en) * 1988-02-17 1993-04-13 Neorx Corporation Anchimeric radiometal chelating compounds
US5326778A (en) * 1992-03-03 1994-07-05 Research Corporation Technologies, Inc. Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy
US5482698A (en) * 1993-04-22 1996-01-09 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin polymer conjugates

Also Published As

Publication number Publication date
WO1998004293A1 (en) 1998-02-05

Similar Documents

Publication Publication Date Title
EP0700304A4 (en) Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
AU1077197A (en) Medical catheters for ablation and detection
AU2103097A (en) Cinnoline derivatives and use as medicine
SG46472A1 (en) Improved detection and therapy of lesions with biotin/avidin polymer conjugates
AU7812998A (en) Versatile stereotactic device and methods of use
AU3890297A (en) Herbal formulation and therapeutic uses therefor
AU6763898A (en) Gel sensors and methods of use thereof
AU5752398A (en) Novel ketobenzamides and their use
AU1807300A (en) Detection of loss of heterozygosity in tumor and serum of melanoma patients
AU3154297A (en) Materials and methods for detection of breast cancer
AU8967998A (en) Antibiotic-ligand conjugates and methods of use thereof
AU4161797A (en) Benzoperimidine-carboxylic acids and derivatives thereof
AU4003597A (en) Methods of diagnosing and treating cancer
AU4528696A (en) Cancer detection probes
AU2242297A (en) Methods for detection and evaluation of bladder cancer
AU3214995A (en) Bis-naphthalimides with linkers having heteroatoms and uses thereof
AU2054797A (en) Isolated human herpesvirus type 8 sequences and uses thereof
AU3118297A (en) Sok-1 and methods of use
AU2087799A (en) Diagnostic and therapeutic methods based upon valpha24jalphaq t cells
AU4047497A (en) Improved detection and therapy of lesions with biotin-chelate conjugates
AU2529799A (en) Benzofuran-4-carboxamides and their therapeutic use
AU6111800A (en) 26 human prostate and prostate cancer associated proteins
AU2512495A (en) Therapeutic phenoxyalkylazoles and phenoxyalkylazines
AU5405298A (en) Needle and needle probe
AU2115197A (en) Compositions and methods useful in the detection and/or treatment of cancerous conditions